Advanced search
Publication Cover
Expert Review of Clinical Pharmacology Volume 11, 2018 - Issue 10
Submit an article Journal homepage
5,256
Views
73
CrossRef citations to date
0
Altmetric
Drug Profile

Clinical and pharmacological profile of benznidazole for treatment of Chagas disease

Jadel Müller KratzChagas Clinical Program, Drugs for Neglected Disease initiative (DNDi), Geneva, SwitzerlandORCID Iconhttps://orcid.org/0000-0002-7681-8234View further author information
ORCID Icon,
Facundo Garcia BournissenParasitology and Chagas Service, Buenos Aires Children Hospital Ricardo Gutiérrez, Buenos Aires, ArgentinaORCID Iconhttps://orcid.org/0000-0002-8732-247XView further author information
ORCID Icon,
Colin J. ForsythChagas Clinical Program, Drugs for Neglected Disease initiative (DNDi), Geneva, SwitzerlandORCID Iconhttps://orcid.org/0000-0003-1481-8367View further author information
ORCID Icon &
Sergio Sosa-EstaniChagas Clinical Program, Drugs for Neglected Disease initiative (DNDi), Geneva, Switzerland;Epidemiology and Public Health Research Center, CONICET, Buenos Aires, ArgentinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8701-5456View further author information
ORCID Icon
Pages 943-957 | Received 02 May 2018, Accepted 06 Aug 2018, Published online: 19 Sep 2018

Citations (73)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Jânio Rodrigo de Jesus Santos, Carlos Augusto Francisco de Jesus & Cláudio Damasceno Pinto. (2021) Scientific mapping of stem cells associated with Chagas disease : A bibliometric analysis. COLLNET Journal of Scientometrics and Information Management 15:2, pages 429-443.
Read now
Fernanda Lascano & Jaime Altcheh. (2021) An evaluation of nifurtimox for Chagas disease in children. Expert Opinion on Orphan Drugs 9:5, pages 139-149.
Read now
Irene Losada Galván, Julio Alonso-Padilla, Nuria Cortés-Serra, Cristina Alonso-Vega, Joaquim Gascón & María Jesús Pinazo. (2021) Benznidazole for the treatment of Chagas disease. Expert Review of Anti-infective Therapy 19:5, pages 547-556.
Read now

Articles from other publishers (70)

Andréa Silvestre de Sousa, Debbie Vermeij, Alberto Novaes RamosJrJr & Alejandro O Luquetti. (2023) Chagas disease. The Lancet.
Crossref
Isadora Cunha Ribeiro, João Victor Badaró de Moraes, Christiane Mariotini-Moura, Marcelo Depolo Polêto, Nancy da Rocha Torres Pavione, Raissa Barbosa de Castro, Izabel Luzia Miranda, Suélen Karine Sartori, Kryssia Lohayne Santos Alves, Gustavo Costa Bressan, Raphael de Souza Vasconcellos, José Roberto Meyer-Fernandes, Gaspar Diaz-Muñoz & Juliana Lopes Rangel Fietto. (2023) Synthesis of new non-natural l-glycosidic flavonoid derivatives and their evaluation as inhibitors of Trypanosoma cruzi ecto-nucleoside triphosphate diphosphohydrolase 1 (TcNTPDase1). Purinergic Signalling.
Crossref
Nailma S. Aprigio-Santos, Carlos F. Estevez-Castro, Juan P. Macedo, Daniela F. Chame, Thiago Castro-Gomes, Mariana Santos-Cardoso, Gabriela A. Burle-Caldas, Courtney N. Covington, Patrick G. Steel, Terry K. Smith, Paul W. Denny & Santuza M. R. Teixeira. (2023) Disruption of the inositol phosphorylceramide synthase gene affects Trypanosoma cruzi differentiation and infection capacity. PLOS Neglected Tropical Diseases 17:9, pages e0011646.
Crossref
Asfiha Tarannum, Cristian Camilo Rodríguez-Almonacid, Jorge Salazar-Bravo & Zemfira N. Karamysheva. (2023) Molecular Mechanisms of Persistence in Protozoan Parasites. Microorganisms 11:9, pages 2248.
Crossref
Patrícia Morais Lopes Pereira, Bruna Terci Fernandes, Vitória Ribeiro dos Santos, Weslei Roberto Correia Cabral, Maria Isabel Lovo-Martins, Lais Alonso, César Armando Contreras Lancheros, Jéssica Carreira de Paula, Priscila Goes Camargo, Helena Tiemi Suzukawa, Antônio Alonso, Fernando MacedoJr.Jr., Celso Vataru Nakamura, Eliandro Reis Tavares, Marcelle de Lima Ferreira Bispo, Lucy Megumi Yamauchi, Phileno Pinge-Filho & Sueli Fumie Yamada-Ogatta. (2023) Antiprotozoal Activity of Benzoylthiourea Derivatives against Trypanosoma cruzi: Insights into Mechanism of Action. Pathogens 12:8, pages 1012.
Crossref
Ariana Jimenez & Elizabeth J. Winokur. (2023) Chagas Disease Cardiomyopathy. Dimensions of Critical Care Nursing 42:4, pages 202-210.
Crossref
Giselle Bedogni, Eva Arrúa, Katia Seremeta, Nora Okulik & Claudio Salomon. (2023) Elucidating the complexation of nifurtimox with cyclodextrins. Journal of Molecular Liquids 382, pages 121852.
Crossref
Marina T. Varela, Maiara Romanelli, Maiara Amaral, Andre G. Tempone & João Paulo S. Fernandes. (2023) Piperazine amides with desirable solubility, physicochemical and drug-like properties: Synthesis and evaluation of the anti-Trypanosoma cruzi activity. Saudi Pharmaceutical Journal 31:7, pages 1265-1273.
Crossref
Carlos S. M. B. Filho, Ramon R. P. P. B. de Menezes, Emanuel P. Magalhães, Yunierkis P. Castillo, Alice M. C. Martins & Damião P. de Sousa. (2023) Piplartine-Inspired 3,4,5-Trimethoxycinnamates: Trypanocidal, Mechanism of Action, and In Silico Evaluation. Molecules 28:11, pages 4512.
Crossref
Kate Sowerby, Stefanie Freitag-Pohl, Ana Milena Murillo, Ariel Mariano Silber & Ehmke Pohl. (2023) Cysteine synthase: multiple structures of a key enzyme in cysteine synthesis and a potential drug target for Chagas disease and leishmaniasis. Acta Crystallographica Section D Structural Biology 79:6, pages 518-530.
Crossref
Jaime Altcheh, Guillermo Moscatelli, Martin Caruso, Samanta Moroni, Margarita Bisio, Maria Rosa Miranda, Celia Monla, Maria Vaina, Maria Valdez, Lucrecia Moran, Teresa Ramirez, Oscar Ledesma Patiño, Adelina Riarte, Nicolas Gonzalez, Jayme Fernandes, Fabiana Alves, Isabela Ribeiro & Facundo Garcia-Bournissen. (2023) Population pharmacokinetics of benznidazole in neonates, infants and children using a new pediatric formulation. PLOS Neglected Tropical Diseases 17:5, pages e0010850.
Crossref
Carlos García-Estrada, Yolanda Pérez-Pertejo, Bárbara Domínguez-Asenjo, Vanderlan Nogueira Holanda, Sankaranarayanan Murugesan, María Martínez-Valladares, Rafael Balaña-Fouce & Rosa M. Reguera. (2023) Further Investigations of Nitroheterocyclic Compounds as Potential Antikinetoplastid Drug Candidates. Biomolecules 13:4, pages 637.
Crossref
Eric Dumonteil, Claudia Herrera & Preston A. Marx. (2023) Safety and preservation of cardiac function following therapeutic vaccination against Trypanosoma cruzi in rhesus macaques. Journal of Microbiology, Immunology and Infection 56:2, pages 400-407.
Crossref
Priscila Silva Grijó Farani, Beatriz Iandra da Silva Ferreira, Khodeza Begum, Glaucia Vilar-Pereira, Isabela Resende Pereira, Edith A. Fernández-Figueroa, Roberto Alejandro Cardenas-Ovando, Igor C. Almeida, Sourav Roy, Joseli Lannes-Vieira & Otacilio Cruz Moreira. (2023) Treatment with benznidazole and pentoxifylline regulates microRNA transcriptomic profile in a murine model of Chagas chronic cardiomyopathy. PLOS Neglected Tropical Diseases 17:3, pages e0011223.
Crossref
Iranildo José da Cruz Filho, Denise Maria Figueiredo Araujo Duarte, Douglas da Conceição Alves de Lima, Diego Santa Clara Marques, Fábio André Brayner dos Santos, Luiz Carlos Alves, André de Lima Aires, Fátima Nogueira & Maria do Carmo Alves de Lima. (2023) In vitro evaluation of alkaline lignins as antiparasitic agents and their use as an excipient in the release of benznidazole. International Journal of Biological Macromolecules 231, pages 123339.
Crossref
Juliana Figueiredo Peixoto, Adriane da Silva Oliveira, Luiz Filipe Gonçalves - Oliveira, Franklin Souza - Silva & Carlos Roberto Alves. (2023) Epoxy-α-lapachone (2,2-Dimethyl-3,4-dihydro-spiro[2H-naphtho[2,3-b]pyran-10,2′-oxirane]-5(10H)-one): a promising molecule to control infections caused by protozoan parasites. The Brazilian Journal of Infectious Diseases 27:2, pages 102743.
Crossref
Giusi Macaluso, Francesca Grippi, Santina Di Bella, Valeria Blanda, Francesca Gucciardi, Alessandra Torina, Annalisa Guercio & Vincenza Cannella. (2023) A Review on the Immunological Response against Trypanosoma cruzi. Pathogens 12:2, pages 282.
Crossref
Natália Magalhães Silva, Cloudo Luiz Colares de Carvalho Júnior & Rossela Damasceno Caldeira. (2023) Perfil epidemiológico e aspectos clínicos da doença de chagas no estado do Pará, durante os anos de 2017 a 2020. Journal of Education Science and Health 3:1, pages 1-12.
Crossref
Leyllane Rafael Moreira, Ana Carla Silva, Cíntia Nascimento da Costa Oliveira, Claudeir Dias da Silva Júnior, Amanda Vasconcelos Nascimento, Kamila Kássia dos Santos Oliveira, Ana Karine de Araújo Soares, Karina Lidianne Alcântara Saraiva, Milena de Paiva Cavalcanti & Virginia Maria Barros de Lorena. (2023) Benznidazole treatment decreases IL-6 levels in Trypanosoma cruzi-infected human adipocytes differentiated from adipose tissue-derived stem cells. Memórias do Instituto Oswaldo Cruz 118.
Crossref
Agustín Ciapponi, Fabiana Barreira, Lucas Perelli, Ariel Bardach, Joaquim Gascón, Israel Molina, Carlos Morillo, Nilda Prado, Adelina Riarte, Faustino Torrico, Juan Carlos Villar, Sara Reidel, Luz Gibbons & Sergio Sosa‐Estani. (2022) Direct evidence gap on fixed versus adjusted‐dose benznidazole for adults with chronic Chagas disease without cardiomyopathy: Systematic review and individual patient data meta‐analysis. Tropical Medicine & International Health 28:1, pages 2-16.
Crossref
Francesco Ramponi, Céline Aerts, Paula Sartor, María Jesús Pinazo, Héctor Freilij, Carlos A. Guzmán, Emilio Malchiodi & Elisa Sicuri. (2023) Development of vaccines for Chagas disease (CRUZIVAX): stakeholders’ preferences and potential impacts on healthcare. Gaceta Sanitaria 37, pages 102275.
Crossref
Maria Letizia Giancola, Angela Corpolongo, Ubaldo Visco Comandini, Franca del Nonno, Marzia Montalbano, Ada Petrone, Stefania Carrara, Andrea Mariano, Alessia Beccacece, Gaetano Maffongelli & Emanuele Nicastri. (2022) Severe drug-induced liver injury (DILI) associated with benznidazole therapy for Chagas’ disease. Journal of Antimicrobial Chemotherapy 77:12, pages 3515-3517.
Crossref
Ramendra P. Pandey, Marilda Savoia Nascimento, Caio Haddad Franco, Karina Bortoluci, Marcelo Nunes Silva, Bianca Zingales, Daniel Gibaldi, Leda Castaño Barrios, Joseli Lannes-Vieira, Leonardo Moro Cariste, Jose Ronnie Vasconcelos, Carolina Borsoi Moraes, Lucio H. Freitas-Junior, Jorge Kalil, Laura Alcântara & Edecio Cunha-Neto. (2022) Drug Repurposing in Chagas Disease: Chloroquine Potentiates Benznidazole Activity against Trypanosoma cruzi In Vitro and In Vivo . Antimicrobial Agents and Chemotherapy 66:11.
Crossref
Steven Van Den Broucke, Maxim Van Herreweghe, Annelies Breynaert, Marjan Van Esbroeck, Carine Truyens, Tess De Bruyne, Nina Hermans & Ralph Huits. (2022) Mitigation of benznidazole toxicity and oxidative stress following ascorbic acid supplementation in an adult traveller with chronic indeterminate Chagas’ disease. Journal of Antimicrobial Chemotherapy 77:6, pages 1748-1752.
Crossref
Christian Bustamante, Andrés Felipe Díez-Mejía, Natalia Arbeláez, Maurilio José Soares, Sara M. Robledo, Rodrigo Ochoa, Rubén E. Varela-M. & Marcel Marín-Villa. (2022) In Silico, In Vitro, and Pharmacokinetic Studies of UBMC-4, a Potential Novel Compound for Treating against Trypanosoma cruzi. Pathogens 11:6, pages 616.
Crossref
Fernanda Lascano, Facundo García Bournissen & Jaime Altcheh. (2021) Review of pharmacological options for the treatment of Chagas disease. British Journal of Clinical Pharmacology 88:2, pages 383-402.
Crossref
Afonso Santine M. M. Velez, Gabriela Alves de Souza, Paulo Pitasse-Santos, Douglas Chaves de Alcântara Pinto, Debora Decote-Ricardo & Marco Edilson Freire de Lima. (2022) 2-Nitro-1-vinyl-1H-imidazole. Molbank 2022:1, pages M1326.
Crossref
Priscila Silva Grijó Farani, Beatriz Iandra Silva Ferreira, Daniel Gibaldi, Joseli Lannes-Vieira & Otacilio Cruz Moreira. (2022) Modulation of miR-145-5p and miR-146b-5p levels is linked to reduced parasite load in H9C2 Trypanosoma cruzi infected cardiomyoblasts. Scientific Reports 12:1.
Crossref
Fernanda de Souza Nogueira Sardinha Mendes, Jose Antonio Perez-Molina, Andrea Angheben, Sheba K Meymandi, Sergio Sosa-Estani & Israel Molina. (2022) Critical analysis of Chagas disease treatment in different countries. Memórias do Instituto Oswaldo Cruz 117.
Crossref
Jadel M Kratz, Karolina R Gonçalves, Lavínia MD Romera, Carolina Borsoi Moraes, Paula Bittencourt-Cunha, Sergio Schenkman, Eric Chatelain & Sergio Sosa-Estani. (2022) The translational challenge in Chagas disease drug development. Memórias do Instituto Oswaldo Cruz 117.
Crossref
Thaisa Lucas Sandri, Kárita Cláudia Freitas Lidani, Fabiana Antunes Andrade, Lais Pessanha Carvalho, Pamela Dias Fontana, Edésio José Tenório de Melo & Iara Jose de Messias-Reason. 2022. Encyclopedia of Infection and Immunity. Encyclopedia of Infection and Immunity 769 792 .
Andre G. Tempone, Pauline Pieper, Samanta E. T. Borborema, Fernanda Thevenard, Joao Henrique G. Lago, Simon L. Croft & Edward A. Anderson. (2021) Marine alkaloids as bioactive agents against protozoal neglected tropical diseases and malaria. Natural Product Reports 38:12, pages 2214-2235.
Crossref
Ramon G. de Oliveira, Luiza R. Cruz, María C. Mollo, Luiz C. Dias & Jadel M. Kratz. (2021) Chagas Disease Drug Discovery in Latin America—A Mini Review of Antiparasitic Agents Explored Between 2010 and 2021. Frontiers in Chemistry 9.
Crossref
Natália Ivanova, Ana Luísa Junqueira Leite, Marcel Barbosa Vieira, Otto Henrique Cezar e Silva, Ludmilla Walter Reis Mota, Guilherme de Paula Costa, Cristiano Schetini de Azevedo, Sarah Alves Auharek, Romulo Dias Novaes, Kelerson Mauro de Castro Pinto, Rodrigo Fernando Bianchi & André Talvani. (2021) New Insights Into Blue Light Phototherapy in Experimental Trypanosoma cruzi Infection. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Nina Svensen, Susan Wyllie, David W. Gray & Manu De Rycker. (2021) Live-imaging rate-of-kill compound profiling for Chagas disease drug discovery with a new automated high-content assay. PLOS Neglected Tropical Diseases 15:10, pages e0009870.
Crossref
Marta LimaLindsay B TullochVictoriano Corpas-LopezSandra CarvalhoRichard J. WallRachel MilneEva RicoStephen PattersonIan H. Gilbert, Sonia MonizLorna MacLeanLeah S. TorrieCarmine MorgilloDavid Horn, Fabio ZuccottoSusan Wyllie. (2021) Identification of a proteasome-targeting arylsulfonamide with potential for the treatment of Chagas’ disease. Antimicrobial Agents and Chemotherapy.
Crossref
Ana Lia Mazzeti, Karolina R. Gonçalves, Suianne L. A. Mota, Dário Elias Pereira, Lívia de F. Diniz & Maria Terezinha Bahia. (2021) Combination therapy using nitro compounds improves the efficacy of experimental Chagas disease treatment. Parasitology 148:11, pages 1320-1327.
Crossref
Michael J.V. da Silva, Andrey P. Jacomini, Davana S. Gonçalves, Karlos Eduardo Pianoski, Julia Poletto, Danielle Lazarin-Bidóia, Hélito Volpato, Celso V. Nakamura & Fernanda A. Rosa. (2021) Discovery of 1,3,4,5-tetrasubstituted pyrazoles as anti-trypanosomatid agents: Identification of alterations in flagellar structure of L. amazonensis. Bioorganic Chemistry 114, pages 105082.
Crossref
Faustino Torrico, Fabiana Barreira, Nathalie Strub-Wourgaft, Isabella Ribeiro & Sergio Sosa-Estani. (2021) Benznidazole in Chagas disease study: do the data justify progression to phase 3? – Authors’ reply. The Lancet Infectious Diseases 21:8, pages 1067.
Crossref
Faustino Torrico, Joaquim Gascón, Fabiana Barreira, Bethania Blum, Igor C Almeida, Cristina Alonso-Vega, Tayná Barboza, Graeme Bilbe, Erika Correia, Wilson Garcia, Lourdes Ortiz, Rudy Parrado, Juan Carlos Ramirez, Isabela Ribeiro, Nathalie Strub-Wourgaft, Michel Vaillant, Sergio Sosa-Estani, Roger Arteaga, Anabelle de la Barra, Jhonny Camacho Borja, Ivana Martinez, Jayme Fernandes, Lineth Garcia, Daniel Lozano, Alejandro Palacios, Alejandro Schijman, Maria Jesus Pinazo, Jimmy Pinto, Gimena Rojas, Igor Estevao, Uriel Ortega-Rodriguez, Maria Tays Mendes, Edgar Schuck, Katsura Hata, Noritsugu Maki & Makoto Asada. (2021) New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial. The Lancet Infectious Diseases 21:8, pages 1129-1140.
Crossref
Priscila Silva Grijó Farani, Khodeza Begum, Glaucia Vilar-Pereira, Isabela Resende Pereira, Igor C. Almeida, Sourav Roy, Joseli Lannes-Vieira & Otacilio Cruz Moreira. (2021) Treatment With Suboptimal Dose of Benznidazole Mitigates Immune Response Molecular Pathways in Mice With Chronic Chagas Cardiomyopathy. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Edio Maldonado, Diego A. Rojas, Fabiola Urbina & Aldo Solari. (2021) The Use of Antioxidants as Potential Co-Adjuvants to Treat Chronic Chagas Disease. Antioxidants 10:7, pages 1022.
Crossref
Kazuro Shiomi. (2021) Antiparasitic antibiotics from Japan. Parasitology International 82, pages 102298.
Crossref
Rocío Herráez, Roberto Quesada, Norma Dahdah, Miguel Viñas & Teresa Vinuesa. (2021) Tambjamines and Prodiginines: Biocidal Activity against Trypanosoma cruzi. Pharmaceutics 13:5, pages 705.
Crossref
Melisa D Castro Eiro, María A Natale, María G Alvarez, Huifeng Shen, Rodolfo Viotti, Bruno Lococo, Jacqueline Bua, Myriam Nuñez, Graciela L Bertocchi, María C Albareda, Gonzalo Cesar, Rick L Tarleton & Susana A Laucella. (2021) Reduced Trypanosoma cruzi -specific humoral response and enhanced T cell immunity after treatment interruption with benznidazole in chronic Chagas disease . Journal of Antimicrobial Chemotherapy 76:6, pages 1580-1592.
Crossref
Marcela S. Rial, Katia P. Seremeta, Mónica I. Esteva, Jacqueline Búa, Claudio J. Salomon & Laura E. Fichera. (2020) In vitro studies and preclinical evaluation of benznidazole microparticles in the acute Trypanosoma cruzi murine model . Parasitology 148:5, pages 566-575.
Crossref
Isabela Ribeiro, Bethania Blum, Jayme Fernandes, Glaucia Santina, Makoto Asada, Michael Everson, Edgar Schuck, Ethel Feleder, Eric Evene & Virginie Gualano. (2021) Drug-Drug Interaction Study of Benznidazole and E1224 in Healthy Male Volunteers. Antimicrobial Agents and Chemotherapy 65:4.
Crossref
Jean Baptiste Hzounda Fokou, Darline Dize, Gisele Marguerite Etame Loe, Moise Henri Julien Nko’o, Jean Pierre Ngene, Charles Christian Ngoule & Fabrice Fekam Boyom. (2021) Anti-leishmanial and anti-trypanosomal natural products from endophytes. Parasitology Research 120:3, pages 785-796.
Crossref
Marisa L. Fernández, María E. Marson, Guido E. Mastrantonio, Marcelo A. Corti, Ulises Fleitas, Susana C. Lloveras, Nicolas Lista, Maria M. Priarone, Cecilia Domínguez & Facundo Garcia-Bournissen. (2021) Benznidazole in Cerebrospinal Fluid: a Case Series of Chagas Disease Meningoencephalitis in HIV-Positive Patients. Antimicrobial Agents and Chemotherapy 65:3.
Crossref
Allison M. Rice, Yueming Long & S. Bruce King. (2021) Nitroaromatic Antibiotics as Nitrogen Oxide Sources. Biomolecules 11:2, pages 267.
Crossref
Paula E. Stigler Granados & Colin J. Forsyth. 2021. Neglected Tropical Diseases - North America. Neglected Tropical Diseases - North America 93 115 .
Javier Martín-Escolano, Encarnación Medina-Carmona & Rubén Martín-Escolano. (2020) Chagas Disease: Current View of an Ancient and Global Chemotherapy Challenge. ACS Infectious Diseases 6:11, pages 2830-2843.
Crossref
Leslie Raphael de Moura Ferraz, Alinne Élida Gonçalves Alves Tabosa, Débora Dolores Souza da Silva Nascimento, Aline Silva Ferreira, Victor de Albuquerque Wanderley Sales, José Yago Rodrigues Silva, Severino Alves Júnior, Larissa Araújo Rolim, Jorge José de Souza Pereira & Pedro José Rolim-Neto. (2020) ZIF-8 as a promising drug delivery system for benznidazole: development, characterization, in vitro dialysis release and cytotoxicity. Scientific Reports 10:1.
Crossref
Agustín Ciapponi, Fabiana Barreira, Lucas Perelli, Ariel Bardach, Joaquim Gascón, Israel Molina, Carlos Morillo, Nilda Prado, Adelina Riarte, Faustino Torrico, Isabela Ribeiro, Juan Carlos Villar & Sergio Sosa-Estani. (2020) Fixed vs adjusted-dose benznidazole for adults with chronic Chagas disease without cardiomyopathy: A systematic review and meta-analysis. PLOS Neglected Tropical Diseases 14:8, pages e0008529.
Crossref
Yara Almeida Machado, Maria Terezinha Bahia, Ivo Santana Caldas, Ana Lia Mazzeti, Rômulo Dias Novaes, Breno Raimundo Vilas Boas, Lorena Júnia de Souza Santos, Olindo Assis Martins-Filho, Marcos José Marques & Lívia de Figueiredo Diniz. (2020) Amlodipine Increases the Therapeutic Potential of Ravuconazole upon Trypanosoma cruzi Infection. Antimicrobial Agents and Chemotherapy 64:8.
Crossref
Eric Dumonteil, Claudia Herrera, Weihong Tu, Kelly Goff, Marissa Fahlberg, Erin Haupt, Amitinder Kaur, Preston A. Marx, Jaime Ortega-Lopez, Peter J. Hotez & Maria Elena Bottazzi. (2020) Safety and immunogenicity of a recombinant vaccine against Trypanosoma cruzi in Rhesus macaques. Vaccine 38:29, pages 4584-4591.
Crossref
María Álvarez-Bardón, Yolanda Pérez-Pertejo, César Ordóñez, Daniel Sepúlveda-Crespo, Nestor M. Carballeira, Babu L. Tekwani, Sankaranarayanan Murugesan, Maria Martinez-Valladares, Carlos García-Estrada, Rosa M. Reguera & Rafael Balaña-Fouce. (2020) Screening Marine Natural Products for New Drug Leads against Trypanosomatids and Malaria. Marine Drugs 18:4, pages 187.
Crossref
Luis Eduardo Echeverría, Rachel Marcus, Gabriel Novick, Sergio Sosa-Estani, Kate Ralston, Ezequiel Jose Zaidel, Colin Forsyth, Antonio Luiz P. Ribeiro, Iván Mendoza, Mariano Luis Falconi, Jorge Mitelman, Carlos A. Morillo, Ana Cristina Pereiro, María Jesús Pinazo, Roberto Salvatella, Felipe Martinez, Pablo Perel, Álvaro Sosa Liprandi, Daniel José Piñeiro & Gustavo Restrepo Molina. (2020) WHF IASC Roadmap on Chagas Disease. Global Heart 15:1, pages 26.
Crossref
Yves Jackson, Baptiste Wyssa & François Chappuis. (2020) Tolerance to nifurtimox and benznidazole in adult patients with chronic Chagas’ disease. Journal of Antimicrobial Chemotherapy 75:3, pages 690-696.
Crossref
Sheila Boreiko, Marcio Silva, Raíssa de F. P. Melo, Ariel M. Silber & Jorge Iulek. (2020) Structure of Urocanate Hydratase from the protozoan Trypanosoma cruzi. International Journal of Biological Macromolecules 146, pages 716-724.
Crossref
Stephanie Maia Acuña, Lucile Maria Floeter-Winter & Sandra Marcia Muxel. (2020) MicroRNAs: Biological Regulators in Pathogen–Host Interactions. Cells 9:1, pages 113.
Crossref
Virgínia Paula Frade, Nathália Soares Simões, Nayara Ragi Baldoni Couto, Cristina Sanches & Cláudia Di Lorenzo Oliveira. (2020) Ideal benznidazole dose regimen in chronic chagasic patients: a systematic review. Revista do Instituto de Medicina Tropical de São Paulo 62.
Crossref
Caryn Bern, Louisa A. Messenger, Jeffrey D. Whitman & James H. Maguire. (2019) Chagas Disease in the United States: a Public Health Approach. Clinical Microbiology Reviews 33:1.
Crossref
Alfonso Herreros-Cabello, Francisco Callejas-Hernández, Manuel Fresno & Núria Gironès. (2019) Comparative proteomic analysis of trypomastigotes from Trypanosoma cruzi strains with different pathogenicity. Infection, Genetics and Evolution 76, pages 104041.
Crossref
Jadel Müller Kratz. (2019) Drug discovery for chagas disease: A viewpoint. Acta Tropica 198, pages 105107.
Crossref
Andréa A.S. Mendonça, Reggiani V. Gonçalves, Thaiany G. Souza-Silva, Izabel R.S.C. Maldonado, André Talvani, Antônio J. Natali & Rômulo D. Novaes. (2019) Concomitant exercise training attenuates the cardioprotective effects of pharmacological therapy in a murine model of acute infectious myocarditis. Life Sciences 230, pages 141-149.
Crossref
Jeremiah D. MomperNathan J. HananSteven S. RossiMark H. MirochnickMaria Luisa CafferataAntonia LaveniaIsolina FloresLuz GibbonsAlvaro CigandaSergio Sosa EstaniEdmund V. CapparelliPierre Buekens. (2019) Determination of Benznidazole in Human Dried Blood Spots by Liquid Chromatography–Mass Spectrometry to Monitor Adherence to Trypanosoma cruzi Infection Treatment in Infants and Children. The American Journal of Tropical Medicine and Hygiene 101:1, pages 116-122.
Crossref
Anacleto S. de Souza, Leonardo L. G. Ferreira, Aldo S. de Oliveira & Adriano D. Andricopulo. (2019) Quantitative Structure–Activity Relationships for Structurally Diverse Chemotypes Having Anti-Trypanosoma cruzi Activity. International Journal of Molecular Sciences 20:11, pages 2801.
Crossref
Leandro Stefano Sangenito, Vanessa da Silva Santos, Claudia Masini d'Avila-Levy, Marta Helena Branquinha, André Luis Souza dos Santos & Simone S.C. de Oliveira. (2019) Leishmaniasis and Chagas Disease – Neglected Tropical Diseases: Treatment Updates. Current Topics in Medicinal Chemistry 19:3, pages 174-177.
Crossref
Alina Perrone, Natalia Milduberger, Alicia Fuchs, Patricia Bustos & Jacqueline Bua. (2018) A Functional Analysis of the Cyclophilin Repertoire in the Protozoan Parasite Trypanosoma Cruzi. Biomolecules 8:4, pages 132.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.